Overview
Si-yu Wang practices in Guangzhou, China. Wang is highly rated in 3 conditions, according to our data. Their top areas of expertise are Lung Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.
Their clinical research consists of co-authoring 33 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung AdenocarcinomaWang isAdvanced. Learn about Lung Adenocarcinoma.
- Lung CancerWang isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Experienced
- Brain TumorWang isExperienced. Learn about Brain Tumor.
- EGFR Positive Lung CancerWang isExperienced. Learn about EGFR Positive Lung Cancer.